Table 1 Demographic variables of feasibility testing participants (n = 9)
Demographic variable | Frequency of demographic n (%) |
|---|---|
Age (median years + IQRa) | 31 (29.5–33.5) |
Ulcerative colitis | 4 (44) |
Crohn’s disease | 5 (56) |
Duration of disease (median years + IQR) | 5.5 (3.5–13) |
Current medications | |
5-aminosalicylates | 3 (33) |
Corticosteroids | 2 (22) |
Immunomodulator (Thiopurine) | 4 (44) |
Biologics | 4 (44) |
Anti-tumour necrosis factor | 4 |
Vedolizumab | 0 |
Ustekinumab | 0 |
Surgical history | |
Yes | 2 (22) |
No | 7 (78) |
Pregnancy stage | |
Preconception | 3 (33) |
Pregnancy | 4 (44) |
Post-partum | 2 (22) |
Currently breastfeeding | |
Yes | 2 (22) |
No | 0 |
Not applicable | 7 (78) |
Prior pregnancies (if pregnant, excludes current) | |
Yes | 5 (56) |
No | 2 (22) |
Marital status | |
Married | 6 (67) |
Common-law | 1 (11) |
Single | 2 (22) |
Highest level of education | |
High school diploma | 2 (22) |
Trade, technical, vocational, business school | 1 (11) |
University undergraduate degree | 3 (33) |
Post graduate degree | 3 (33) |
Total income (CAD/AUS $) | |
20,000–39,990 | 1 (11) |
40,000–69,900 | 1 (11) |
70,000–99,000 | 2 (22) |
100,000+ | 5 (56) |